Sales rise 38.37% to Rs 694.27 crore
On 9 May 2022
The companys PAT declines 14% yoy at Rs58.3cr in Q3FY22.
Of Rs.1 per share
Record date is 10 February 2022
Sales rise 19.72% to Rs 634.80 crore
Sales rise 25.65% to Rs 593.21 crore
On 31 January 2022
Aarti Drugs fell 2.24% to Rs 552.65, extending decline for second day.
The companys consolidated revenue for Q2FY22 stood at Rs579.7cr as against Rs578.4cr in Q2FY21.
Per Order for ETF & Mutual Funds Brokerage
Per Order for Delivery, Intraday, F&O, Currency & Commodity